Decapeptide-12 Peptide – The Targeted Tyrosinase Inhibitor for Research
Decapeptide-12, also studied under the name Lumixyl, is a specialized sequence of twelve amino acids designed to modulate the skin’s pigmentary response. In dermatological research, it is highly valued for its safety profile and its specific antagonistic action against the pathways that lead to dysregulated melanin synthesis.
Key Research Areas:
- Tyrosinase Enzyme Restriction: The primary function of Decapeptide-12 is to restrain Tyrosinase, the copper-containing enzyme that catalyzes the production of melanin. By limiting this enzyme’s activity, researchers investigate how to prevent the formation of patchy pigmentation and dark spots on the epidermal surface.
- Selective Pigment Modulation: Unlike traditional research compounds (such as hydroquinone) which may be toxic to melanocytes, Decapeptide-12 is studied for its ability to reduce pigment production through enzymatic competition rather than cell destruction.
- Melasma & Post-Inflammatory Research: Studies focus on the peptide’s efficacy in treating melasma and post-inflammatory hyperpigmentation (PIH). It provides a model for observing the stabilization of melanocyte activity in hyper-reactive skin types.
- Skin Clarity & Photo-Damage: Researchers use Decapeptide-12 to investigate the reversal of UV-induced pigmentation and the restoration of a uniform skin tone in photo-aged research models.
- Stability & Bioavailability: With a molecular weight of 1311.46 g/mol, the peptide is synthesized to ensure high purity and structural integrity, allowing for consistent data in long-term dermal signaling assays.
Elite Peptide Supply provides high-purity Decapeptide-12 for specialized laboratory experimentation. Our peptide is synthesized to ensure the specific Tyr-Arg-Ser motif remains active for high-affinity tyrosinase targeting.
Reviews
There are no reviews yet.